Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$3.62 - $5.23 $97,703 - $141,157
-26,990 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$3.94 - $8.19 $38,127 - $79,254
9,677 Added 55.89%
26,990 $136,000
Q4 2020

Feb 16, 2021

BUY
$3.99 - $5.7 $21,705 - $31,008
5,440 Added 45.82%
17,313 $71,000
Q3 2020

Nov 12, 2020

BUY
$4.38 - $6.43 $4,936 - $7,246
1,127 Added 10.49%
11,873 $58,000
Q2 2020

Aug 13, 2020

BUY
$3.0 - $6.9 $32,238 - $74,147
10,746 New
10,746 $60,000
Q1 2020

May 14, 2020

SELL
$2.36 - $9.86 $76,541 - $319,789
-32,433 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.69 - $4.92 $11,655 - $21,318
4,333 Added 15.42%
32,433 $146,000
Q3 2019

Nov 14, 2019

SELL
$2.59 - $4.16 $19,409 - $31,175
-7,494 Reduced 21.05%
28,100 $116,000
Q2 2019

Aug 14, 2019

BUY
$3.6 - $4.78 $126,698 - $168,227
35,194 Added 8798.5%
35,594 $134,000
Q1 2019

May 15, 2019

SELL
$2.62 - $4.44 $133,287 - $225,876
-50,873 Reduced 99.22%
400 $1,000
Q4 2018

Feb 14, 2019

SELL
$2.28 - $7.15 $28,789 - $90,283
-12,627 Reduced 19.76%
51,273 $127,000
Q3 2018

Nov 14, 2018

SELL
$3.85 - $7.35 $100,485 - $191,835
-26,100 Reduced 29.0%
63,900 $466,000
Q2 2018

Aug 14, 2018

BUY
$3.7 - $5.65 $250,741 - $382,889
67,768 Added 304.82%
90,000 $333,000
Q1 2018

May 15, 2018

SELL
$3.65 - $5.2 $116,037 - $165,313
-31,791 Reduced 58.85%
22,232 $85,000
Q4 2017

Feb 14, 2018

SELL
$3.4 - $4.15 $138,179 - $168,660
-40,641 Reduced 42.93%
54,023 $194,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $336,057 - $496,986
94,664
94,664 $373,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.